ATLANTA -- Federal health officials said Thursday they are confident about the accuracy of the main antibody test being used to screen people for SARS. The Centers for Disease Control and Prevention ...

SAN DIEGO, Sept. 22, 2025 /PRNewswire/ -- Building on its leadership in point-of-care diagnostic testing, QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho"), a leading global provider of ...

SAN DIEGO, Sept. 22, 2025 /PRNewswire/ -- Building on its leadership in point-of-care diagnostic testing, QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho (QDEL)"), a leading global provider of ...

Scientists at Washington University in St. Louis reported filing patent protection for their breath test that quickly identifies those infected with SARS-CoV-2, requires only one or two breaths to be ...

Last week, QuidelOrtho Corporation QDEL announced the availability of QUICKVUE Influenza + SARS Test. The CLIA-waived, 510(k)–cleared rapid, easy-to-use immunoassay is the latest addition to the ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Labor & delivery units may need to consider regional prevalence of COVID-19 when deciding whether ...

The granting of emergency use authorization by the U.S. FDA to Roche AG for its four-in-one molecular test for SARS-CoV-2, Influenza A/B viruses and respiratory syncytial virus will allow the company ...

Tests for the SARS virus will soon help doctors sort out whether people with worrisome coughs and fevers actually have the new respiratory illness, relieving anxiety for many and helping judge who ...

OBJECTIVESTo determine whether time elapsed since the second injection of the Pfizer-BioNTech BNT162b2 mRNA vaccine was significantly associated with the risk of covid-19 infection after vaccination ...